Stella Safo, MD, MPH and Michael Angarone, DO, FIDSA discuss how the Omicron variant is impacting COVID-19 treatment decisions. Topics: *Are monoclonal antibodies effective against Omicron and other variants? *Prevalence of the Omicron variant *What are the other variants of concern? *Bob is 70 with lung cancer and SARS-CoV-2 positive - how can you treat him? *Addressing racial inequities
Credit available: 1.0 of AMA, ANCC, AAPA, or ACPE
Faculty
Just Equity For Health, Founder and Executive Director
Assistant Professor Mount Sinai Health System
Associate Professor
Division of Infectious Diseases
Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine